1. Home
  2. TX vs CORT Comparison

TX vs CORT Comparison

Compare TX & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ternium S.A. Ternium S.A. (each representing ten shares USD1.00 par value)

TX

Ternium S.A. Ternium S.A. (each representing ten shares USD1.00 par value)

HOLD

Current Price

$55.26

Market Cap

10.9B

Sector

Industrials

ML Signal

HOLD

Logo Corcept Therapeutics Incorporated

CORT

Corcept Therapeutics Incorporated

HOLD

Current Price

$120.92

Market Cap

9.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TX
CORT
Founded
1961
1998
Country
Luxembourg
United States
Employees
33253
N/A
Industry
Steel/Iron Ore
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.9B
9.7B
IPO Year
2006
2001

Fundamental Metrics

Financial Performance
Metric
TX
CORT
Price
$55.26
$120.92
Analyst Decision
Hold
Buy
Analyst Count
5
5
Target Price
$37.70
$96.50
AVG Volume (30 Days)
689.2K
1.1M
Earning Date
05-05-2026
04-30-2026
Dividend Yield
6.31%
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.09
Revenue
N/A
$761,407,000.00
Revenue This Year
$9.60
$26.08
Revenue Next Year
$6.66
$26.98
P/E Ratio
$20.15
$1,345.00
Revenue Growth
N/A
12.79
52 Week Low
$32.11
$28.66
52 Week High
$55.66
$122.21

Technical Indicators

Market Signals
Indicator
TX
CORT
Relative Strength Index (RSI) 70.11 70.05
Support Level $41.60 $77.73
Resistance Level $55.66 $122.21
Average True Range (ATR) 1.71 3.53
MACD -0.00 0.20
Stochastic Oscillator 66.02 84.57

Price Performance

Historical Comparison
TX
CORT

About TX Ternium S.A. Ternium S.A. (each representing ten shares USD1.00 par value)

Ternium SA is a flat steel producer operating in Mexico, Brazil, Argentina, Colombia, the southern United States, and Central America. It produces finished and semi-finished steel products and iron ore, which are sold either directly to steel manufacturers and steel processors or end-users. The company operates in two segments: Steel and Mining. In its Steel segment, the company produces slabs, billets & round bars, hot-rolled coils & sheets, bars & stirrups, wire rods, steel pipes, and other products. The Mining segment sells iron ore as concentrates (fines) and pellets. The vast majority of its revenue comes from the Steel segment and geographically from Mexico.

About CORT Corcept Therapeutics Incorporated

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic, and neuropsychiatric disorders by modulating the effect of the cortisol hormone. The company markets Korlym (mifepristone) tablets and its authorized generic version, which is an oral medication for the treatment of hypercortisolism (also known as Cushing's syndrome). Additionally, its pipeline contains several key compounds, such as Relacorilant, Dazucorilant, Miricorilant, etc., that are being evaluated in clinical trials as potential treatments for a variety of serious disorders like hypercortisolism, solid tumors (including ovarian, endometrial, cervical, pancreatic, and prostate cancers), ALS, and MASH.

Share on Social Networks: